Sun Pharma gets approval for generic Gemzar injection

Published on Fri, Mar 07, 2008 at 12:27 |  Source : Moneycontrol.com

Updated at Fri, Mar 07, 2008 at 13:14  

24312 Investors following Sun Pharma. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for its generic version of Eli Lilly and Co's Gemzar®, gemcitabine injection.

 

These generic gemcitabine injections are therapeutic equivalents of Eli Lilly and Co's Gemzar® injections available in two strengths: 200 mg and 1 g single use vial. These strengths of gemcitabine injections have annual sales of approximately USD 680 million in the US.

 

Gemcitabine is an anticancer, used singly or in combination with other anticancer agents. 

 

Sourced from: Sun Pharmaceutical Industries Ltd

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com